Vita Coco (COCO) CEO Roper sells 50K shares after exercising options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vita Coco Company, Inc. CEO Martin Roper exercised stock options and sold shares in a planned set of trades. He exercised 25,000 non-qualified stock options at an exercise price of $10.178 per share on each of two days, receiving 50,000 shares of common stock.
On those same days he sold 25,000 shares at $50.00 and 25,000 shares at a weighted average price of $50.107, with actual sale prices ranging from $50.00 to $50.30, under a Rule 10b5-1 trading plan. After these transactions, he directly owns 298,484 common shares and continues to hold multiple option awards with exercise prices between $10.178 and $32.780, as well as indirect holdings through family trusts and his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 50,000 shares ($2,502,675)
Net Sell
16 txns
Insider
Roper Martin
Role
Chief Executive Officer
Sold
50,000 shs ($2.50M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | -- |
| Exercise | Common Stock | 25,000 | $10.178 | $254K |
| Sale | Common Stock | 25,000 | $50.107 | $1.25M |
| Exercise | Non-Qualified Stock Option (Right to Buy) | 25,000 | $0.00 | -- |
| Exercise | Common Stock | 25,000 | $10.178 | $254K |
| Sale | Common Stock | 25,000 | $50.00 | $1.25M |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (Right to Buy) — 450,214 shares (Direct);
Common Stock — 323,484 shares (Direct);
Common Stock — 215,631 shares (Indirect, by Chris Roper FT)
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.30, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Christopher G. Roper Exempt Family Trust. These shares are held by the Peter S. Roper Exempt Family Trust. These shares are held by the Thomas L. Roper Exempt Family Trust. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The stock option vests in four equal annual installments beginning on March 3, 2026.
Key Figures
Options exercised: 50,000 shares
Option exercise price: $10.178 per share
Shares sold: 50,000 shares
+5 more
8 metrics
Options exercised
50,000 shares
Non-qualified stock options exercised via code M transactions
Option exercise price
$10.178 per share
Exercise price for the 50,000 options converted to common stock
Shares sold
50,000 shares
Open-market sales coded S across two days
Sale prices
$50.00–$50.30 per share
Weighted averages of $50.00 and $50.107 with stated range
Direct holdings after
298,484 shares
Total common stock directly owned after the reported transactions
Remaining options (low strike)
40,950 underlying shares at $10.178
Non-qualified stock option expiring on 2031-01-11
Remaining options (mid strike)
298,507 underlying shares at $15.000
Non-qualified stock option expiring on 2031-10-21
Remaining options (higher strike)
70,715 underlying shares at $32.780
Non-qualified stock option expiring on 2035-03-03
Key Terms
Non-Qualified Stock Option (Right to Buy), Rule 10b5-1 trading plan, weighted average price, Exempt Family Trust, +1 more
5 terms
Non-Qualified Stock Option (Right to Buy) financial
"security_title: Non-Qualified Stock Option (Right to Buy)"
Rule 10b5-1 trading plan regulatory
"sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Exempt Family Trust financial
"These shares are held by the Christopher G. Roper Exempt Family Trust."
stock option vests in four equal annual installments financial
"The stock option vests in four equal annual installments beginning on March 10, 2024."
FAQ
What did Vita Coco (COCO) CEO Martin Roper do in this Form 4 filing?
Martin Roper exercised stock options for 50,000 Vita Coco shares, then sold 50,000 shares in open-market transactions. The trades were reported as part of a disclosed Rule 10b5-1 trading plan, indicating they were pre-arranged rather than discretionary market timing.
Were the Vita Coco (COCO) CEO’s stock sales under a Rule 10b5-1 trading plan?
Yes. A footnote states the common stock sales were effected under a Rule 10b5-1 trading plan. Such plans are established in advance and execute automatically, so the timing of these sales is pre-planned rather than a reaction to short-term market or company developments.
What stock options does the Vita Coco (COCO) CEO still hold after this Form 4?
The derivative summary shows several remaining non-qualified stock options on Vita Coco common stock. Exercise prices range from $10.178 to $32.780, with expirations between 2031 and 2035, providing the CEO ongoing equity exposure if these options are exercised later.